Very early researchLooking for participantsNCT07695012What this trial is testingCAR-T Cell Therapy for ALLWho this might be right forRelapsed Acute Lymphoblastic Leukemia (ALL) Dr. Zaineb Akram 10
Not applicableLooking for participantsNCT06600568What this trial is testingNovel Therapeutic Approach for Human T-cell MalignanciesWho this might be right forT-Cell Leukemia/Lymphoma, Adult Istituto Oncologico Veneto IRCCS 120
Not applicableStudy completedNCT01626183What this trial is testingStudying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Children's Oncology Group 20
Early research (Phase 1)Study completedNCT00098423What this trial is testingTanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic SyndromesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+23 more National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Ended earlyNCT01044745What this trial is testingRituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more University of Nebraska 20
Early research (Phase 1)Study completedNCT00025129What this trial is testingVNP40101M in Treating Patients With Advanced Solid Tumors or LymphomasWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific Vion Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00005802What this trial is testingChemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic LeukemiaWho this might be right forLeukemia Fred Hutchinson Cancer Center
Not applicableStudy completedNCT00003538What this trial is testingPrevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Ended earlyNCT00469820What this trial is testingVaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell TransplantWho this might be right forLeukemiaMultiple Myeloma and Plasma Cell Neoplasm Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Not applicableStudy completedNCT00321880What this trial is testingHealing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic LeukemiaWho this might be right forFatigueLeukemiaPsychosocial Effects of Cancer and Its Treatment Wake Forest University Health Sciences 40
Testing effectiveness (Phase 2)Study completedNCT00217425What this trial is testingBevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell NeoplasmsWho this might be right forLymphoma Eastern Cooperative Oncology Group 46
Large-scale testing (Phase 3)Ended earlyNCT00324324What this trial is testingMoxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more OHSU Knight Cancer Institute 240
Early research (Phase 1)Looking for participantsNCT04318678What this trial is testingCD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)Who this might be right forAML/MDSB-ALLT-ALL+1 more St. Jude Children's Research Hospital 108
Large-scale testing (Phase 3)Study completedNCT00005590What this trial is testingLevofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or LymphomaWho this might be right forBrain and Central Nervous System TumorsBreast CancerExtragonadal Germ Cell Tumor+7 more Cancer Research Campaign Clinical Trials Centre
Testing effectiveness (Phase 2)Looking for participantsNCT04150497What this trial is testingPhase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)Who this might be right forB-cell Acute Lymphoblastic Leukemia Cellectis S.A. 52
Large-scale testing (Phase 3)Ended earlyNCT00060385What this trial is testingCombination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma European Organisation for Research and Treatment of Cancer - EORTC 3
Testing effectiveness (Phase 2)Study completedNCT04975555What this trial is testingStudy to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell TherapyWho this might be right forCytokine Release SyndromeICANSLymphoma, Non-Hodgkin+2 more University of Alabama at Birmingham 20
Early research (Phase 1)Study completedNCT00878189What this trial is testingA Trial In Patients With Advanced Cancer And LeukemiaWho this might be right forNeoplasms by Histologic Type Pfizer 72
Early research (Phase 1)Study completedNCT00006213What this trial is testingBMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid LeukemiaWho this might be right forAdult Acute Promyelocytic Leukemia (M3)Blastic Phase Chronic Myelogenous LeukemiaChildhood Myelodysplastic Syndromes+8 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)UnknownNCT04778579What this trial is testingStudy of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to TherapyWho this might be right forAcute Lymphoid Leukemia Sara V. Latorre 50